MedTrace Logo

Impact of Inhaled Tranexamic Acid in Pulmonary Hemorrhage in Pediatric Intensive Care Unit

NCT07481682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-19

No results posted yet for this study

Summary

This study aimed to detect the impact of inhaled Tranexamic acid® in pulmonary hemorrhage in pediatric intensive care unit.

Conditions

  • Tranexamic Acid
  • Pulmonary Hemorrhage
  • Pediatric
  • Intensive Care Unit

Interventions

DRUG

Tranexamic acid + conventional therapy.

Patients received inhaled or endotracheally instilled Tranexamic acid (TXA) in addition to conventional therapy.

DRUG

Tranexamic acid

Patients received conventional systemic Tranexamic acid (TXA) alone.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
216 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-09-01
Completion
2024-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07481682 on ClinicalTrials.gov